VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company…
Recent agreements with two additional U.S. mental health providers bring total to four in 2025 Strategy seeks to drive long-term…
Recent agreements with two additional U.S. mental health providers bring total to four in 2025 Strategy seeks to drive long-term…
Recent agreements with two additional U.S. mental health providers bring total to four in 2025 Strategy seeks to drive long-term…
Advances made in preclinical pipeline addressing neurodegenerative diseasesEvotec receives US$ 25 m payment to support continued progression of joint programs…
Q3: continued sales and earnings progress Paris, October 24, 2025 Q3 sales growth of 7.0% at CER1 and business earnings…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY…
In this free webinar, gain insight into enhanced efficiency and cost savings through automated processes like proposal development, feasibility analysis…
As part of the Institute's newly launched AI Initiative, Sumner Magruder, Ph.D., will embed cutting-edge computational tools into foundational biology…
New Initiative – Set to Leverage Data from Human Phenotype Project – Aims to Bring Life Sciences Products to Market…